These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 20370631)

  • 1. Development of safe and efficacious viral vaccines for animals.
    Yilma T; Verardi P; Jones L
    Crit Rev Immunol; 2010; 30(3):223-37. PubMed ID: 20370631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccinia viruses with a serpin gene deletion and expressing IFN-gamma induce potent immune responses without detectable replication in vivo.
    Legrand FA; Verardi PH; Chan KS; Peng Y; Jones LA; Yilma TD
    Proc Natl Acad Sci U S A; 2005 Feb; 102(8):2940-5. PubMed ID: 15705716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of potent humoral and cell-mediated immune responses by attenuated vaccinia virus vectors with deleted serpin genes.
    Legrand FA; Verardi PH; Jones LA; Chan KS; Peng Y; Yilma TD
    J Virol; 2004 Mar; 78(6):2770-9. PubMed ID: 14990697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-18 expression results in a recombinant vaccinia virus that is highly attenuated and immunogenic.
    Verardi PH; Legrand FA; Chan KS; Peng Y; Jones LA; Yilma TD
    J Interferon Cytokine Res; 2014 Mar; 34(3):169-78. PubMed ID: 24168450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic Analysis, Phenotype, and Virulence of the Historical Brazilian Smallpox Vaccine Strain IOC: Implications for the Origins and Evolutionary Relationships of Vaccinia Virus.
    Medaglia ML; Moussatché N; Nitsche A; Dabrowski PW; Li Y; Damon IK; Lucas CG; Arruda LB; Damaso CR
    J Virol; 2015 Dec; 89(23):11909-25. PubMed ID: 26378174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving recombinant MVA immune responses: potentiation of the immune responses to HIV-1 with MVA and DNA vectors expressing Env and the cytokines IL-12 and IFN-gamma.
    Abaitua F; Rodríguez JR; Garzón A; Rodríguez D; Esteban M
    Virus Res; 2006 Mar; 116(1-2):11-20. PubMed ID: 16214252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of a vaccine strain of vaccinia virus via inactivation of interferon viroceptor.
    Dénes B; Gridley DS; Fodor N; Takátsy Z; Timiryasova TM; Fodor I
    J Gene Med; 2006 Jul; 8(7):814-23. PubMed ID: 16634110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Virulence of Different Vaccinia Virus Strains Is Directly Proportional to Their Ability To Downmodulate Specific Cell-Mediated Immune Compartments
    de Freitas LFD; Oliveira RP; Miranda MCG; Rocha RP; Barbosa-Stancioli EF; Faria AMC; da Fonseca FG
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30567985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanding the repertoire of Modified Vaccinia Ankara-based vaccine vectors via genetic complementation strategies.
    Garber DA; O'Mara LA; Zhao J; Gangadhara S; An I; Feinberg MB
    PLoS One; 2009; 4(5):e5445. PubMed ID: 19421328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity and safety of defective vaccinia virus lister: comparison with modified vaccinia virus Ankara.
    Ober BT; Brühl P; Schmidt M; Wieser V; Gritschenberger W; Coulibaly S; Savidis-Dacho H; Gerencer M; Falkner FG
    J Virol; 2002 Aug; 76(15):7713-23. PubMed ID: 12097585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A vaccinia virus double recombinant expressing the F and H genes of rinderpest virus protects cattle against rinderpest and causes no pock lesions.
    Giavedoni L; Jones L; Mebus C; Yilma T
    Proc Natl Acad Sci U S A; 1991 Sep; 88(18):8011-5. PubMed ID: 1896447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of an attenuated TE3L-deficient vaccinia virus Tian Tan strain.
    Wang Y; Kan S; Du S; Qi Y; Wang J; Liu L; Ji H; He D; Wu N; Li C; Chi B; Li X; Jin N
    Antiviral Res; 2012 Dec; 96(3):324-32. PubMed ID: 23084929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety mechanism assisted by the repressor of tetracycline (SMART) vaccinia virus vectors for vaccines and therapeutics.
    Grigg P; Titong A; Jones LA; Yilma TD; Verardi PH
    Proc Natl Acad Sci U S A; 2013 Sep; 110(38):15407-12. PubMed ID: 23988330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant Isfahan Virus and Vesicular Stomatitis Virus Vaccine Vectors Provide Durable, Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge.
    Nasar F; Matassov D; Seymour RL; Latham T; Gorchakov RV; Nowak RM; Leal G; Hamm S; Eldridge JH; Tesh RB; Clarke DK; Weaver SC
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccinia virus vectors with an inactivated gamma interferon receptor homolog gene (B8R) are attenuated In vivo without a concomitant reduction in immunogenicity.
    Verardi PH; Jones LA; Aziz FH; Ahmad S; Yilma TD
    J Virol; 2001 Jan; 75(1):11-8. PubMed ID: 11119568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing the effects of insertion of a 5.2 kb region of a VACV genome, which contains known immune evasion genes, on MVA immunogenicity.
    Ryerson MR; Shisler JL
    Virus Res; 2018 Feb; 246():55-64. PubMed ID: 29341877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a self-inactivating lentiviral vector expressing simian immunodeficiency virus gag for induction of specific immune responses in vitro and in vivo.
    Buffa V; Negri DR; Leone P; Borghi M; Bona R; Michelini Z; Compagnoni D; Sgadari C; Ensoli B; Cara A
    Viral Immunol; 2006; 19(4):690-701. PubMed ID: 17201664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction and evaluation of DNA vaccine encoding Hantavirus glycoprotein N-terminal fused with lysosome-associated membrane protein.
    Jiang DB; Sun YJ; Cheng LF; Zhang GF; Dong C; Jin BQ; Song CJ; Ma Y; Zhang FL; Yang K
    Vaccine; 2015 Jun; 33(29):3367-76. PubMed ID: 26027907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower levels of gamma interferon expressed by a pseudotyped single-cycle simian immunodeficiency virus enhance immunogenicity in rats.
    Peng Y; Lin FC; Verardi PH; Jones LA; Yilma TD
    J Virol; 2009 Feb; 83(4):1592-601. PubMed ID: 19073726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8+ lymphocyte antiviral activity in monkeys immunized with SIV recombinant poxvirus vaccines: potential role in vaccine efficacy.
    Leno M; Carter L; Venzon DJ; Romano J; Markham PD; Limbach K; Tartaglia J; Paoletti E; Benson J; Franchini G; Robert-Guroff M
    AIDS Res Hum Retroviruses; 1999 Mar; 15(5):461-70. PubMed ID: 10195756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.